PharmGen Science, Inc. (004720.KS) KSC

Currency In KRW

AD

Valuation

Market Cap91.22B
Enterprise Value75.34B
P/E Ratio-0.51
PEG Ratio0
Price/Sales Ratio0.39
Price/Book Ratio0.49
Enterprise/Revenue0.28
Enterprise/EBITDA5.78

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.77
Operating Margin0.02
AD

Management Effectiveness

Return On Assets-0.73
Return On Equity-0.79

Income Statement

Revenue173.07B
Revenue/Share7,926.99
Gross Profit109.13B
EBITDA10.53B
Net Income-116.64B
Diluted EPS-5,312.85

Balance Sheet

Total Cash20.05B
Total Cash/Share906.42
Total Debt698.14M
Total Debt/Equity0
Current Ratio3.33
Book Value Per Share6,330.33

Price History

52-Week Change-29.62
52-Week High4,600
52-Week Low2,590
Moving Average 50 Days3,172.2
Moving Average 200 Days3,743.23

Statistics

Average Volume45,324
Shares Outstanding21.91M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:10
Last Split DateDecember 09, 2014
AD